Association of Fusobacterium nucleatum Levels by ddPCR in Oral Rinse Samples With Periodontal Disease in Oral Squamous Cell Carcinoma Patients and in Controls.

Autor: Fernandes BB; Department of Oral Cancer Prevention, Barretos Cancer Hospital, Barretos, Brazil.; Department of Dentistry, Barretos Cancer Hospital, Barretos, Brazil., Datorre JG; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Vazquez FL; Department of Oral Cancer Prevention, Barretos Cancer Hospital, Barretos, Brazil.; Department of Dentistry, Barretos Cancer Hospital, Barretos, Brazil., Peters ACC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Coracin FL; Department of Oral Cancer Prevention, Barretos Cancer Hospital, Barretos, Brazil.; Department of Dentistry, Barretos Cancer Hospital, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal., Arantes LMRB; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Gama RR; Head and Neck Surgery Department, Barretos Cancer Hospital, Barretos, Brazil.

Publikováno v: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology [J Oral Pathol Med] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.

Repurposing discarded leukodepletion filters as a source of mononuclear cells for advanced in vitro research.

Autor: Lima JA; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., Sorroche BP; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., Tostes K; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., Dias TC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., de Carvalho Rodrigues N; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., Tansini A; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, SP, Brazil., da Silva Oliveira RJ; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos School of Health Sciences Dr. Paulo Prata-FACISB, Barretos, SP, Brazil., Arantes LMRB; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Vilela - 1301/1302, Doutor Paulo Prata, 14784400 Barretos, SP, Brazil. Electronic address: lirebolho@hotmail.com.

Publikováno v: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113694. Date of Electronic Publication: 2024 May 24.

An industrialized diet as a determinant of methylation in the 1F region of the NR3C1 gene promoter.

Autor: Vieira TDS; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Freitas FV; Department of Pharmacy and Nutrition, Federal University of Espírito Santo, Alegre, Brazil., Silva Neto LCB; Program of Post-Graduation in Nutrition and Health, Federal University of Espírito Santo, Vitória, Brazil., Borçoi AR; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Mendes SO; Department of Morphology, Federal University of Espirito Santo, Vitória, Brazil., Olinda AS; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Moreno IAA; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Quaioto BR; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., de Souza MLM; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Barbosa WM; Department of Pharmacy and Nutrition, Federal University of Espírito Santo, Alegre, Brazil., Arpini JK; Department of Biology, Federal University of Espirito Santo, Alegre, Brazil., Sorroche BP; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Assis Pinheiro J; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Archanjo AB; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Dos Santos JG; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil., Arantes LMRB; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Oliveira DR; Department of Pharmacology and Medical Toxicology, College of Wisconsin, Milwaukee, WI, United States., da Silva AMA; Program of Post-Graduation in Biotechnology/Renorbio, Federal University of Espírito Santo, Vitória, Brazil.; Department of Morphology, Federal University of Espirito Santo, Vitória, Brazil.

Publikováno v: Frontiers in nutrition [Front Nutr] 2024 Apr 03; Vol. 11, pp. 1168715. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).

HOXA1 3'UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma.

Autor: Sorroche BP; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil., Miranda KC; Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos 12224-300, Brazil., Beltrami CM; International Research Center, A.C. Camargo Cancer Center, São Paulo 01508-010, Brazil., Arantes LMRB; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil., Kowalski LP; Head and Neck Surgery and Otorhinolaryngology Department, AC Camargo Cancer Center, Latin American Cooperative Oncology Group, São Paulo 01509-010, Brazil.; Head and Neck Surgery Department and LIM 28, University of São Paulo Medical School, São Paulo 01246-903, Brazil., Marchi FA; Center for Translational Research in Oncology, Cancer Institute of the State of São Paulo (ICESP), São Paulo 01246-000, Brazil.; Clinical Hospital of the University of Sao Paulo Medical School (HCFMUSP), São Paulo 05403-010, Brazil., Rogatto SR; Department of Clinical Genetics, University Hospital of Southern Denmark, 7100 Vejle, Denmark.; Institute of Regional Health Research, University of Southern Denmark, 5230 Odense, Denmark., Almeida JD; Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos 12224-300, Brazil.

Publikováno v: Cancers [Cancers (Basel)] 2024 Feb 22; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 22.

Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.

Autor: Kinker GS; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Vitiello GAF; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Diniz AB; Hospital Israelita Albert Einstein, São Paulo, Brazil., Cabral-Piccin MP; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Pereira PHB; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Carvalho MLR; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Ferreira WAS; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil.; Evandro Chagas Institute, Ananindeua, Brazil., Chaves AS; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Rondinelli A; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Gusmão AF; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Defelicibus A; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil., Dos Santos GO; Department of Pathology, A.C.Camargo Cancer Center, São Paulo, Brazil., Nunes WA; Department of Pathology, A.C.Camargo Cancer Center, São Paulo, Brazil., Claro LCL; Faculty of Medical Sciences, Santa Casa de Misericórdia do Estado de São Paulo, São Paulo, Brazil., Bernardo TM; Faculty of Medical Sciences, Santa Casa de Misericórdia do Estado de São Paulo, São Paulo, Brazil., Nishio RT; Faculty of Medical Sciences, Santa Casa de Misericórdia do Estado de São Paulo, São Paulo, Brazil., Pacheco AM; Faculty of Medical Sciences, Santa Casa de Misericórdia do Estado de São Paulo, São Paulo, Brazil., Laus AC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Arantes LMRB; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Fleck JL; Mines Saint-Etienne, Univ Clermont Auvergne, CNRS, UMR 6158 LIMOS, Centre CIS, Saint-Etienne, France., de Jesus VHF; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., de Moricz A; Faculty of Medical Sciences, Santa Casa de Misericórdia do Estado de São Paulo, São Paulo, Brazil., Weinlich R; Hospital Israelita Albert Einstein, São Paulo, Brazil., Coimbra FJF; Department of Surgical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., de Lima VCC; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., Medina TDS; International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil tiago.medina@accamargo.org.br.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil.

Publikováno v: Gut [Gut] 2023 Oct; Vol. 72 (10), pp. 1927-1941. Date of Electronic Publication: 2023 May 25.